Contact, Regenocyte International, Zannos Grekos, MD CSO
Chief Science Officer Zannos Grekos, MD, Regenocyte is an international corporation, dedicated to leading the world in providing Adult Stem Cell Treatment. For many patients, Regenocyte Worldwide provides the safest, most effective technologies and advanced medical procedures to improve and prolong the lives of our patients. Regenocyte Worldwide has been treating patients since 2006. Dr Zannos G. Grekos is a guest lecturer at Florida Southwestern College at the Cardiovascular Technology Program and does not practice medicine in the United States.
Also important is that since we have experience with multiple sources from the patient for stem cells, we are able to pick the most effective type for that individual patient. We always use cells sourced from the patient. And in genetic cases we can use cells from a matched relative. Utilization of more than one type of stem cell is extremely important in most cases. For instance, in utilizing stem cells that come from both bone marrow and fat we are allowing for the two cell types to interact and gain benefit from each other. The stem cells that come from fat are not very active in increasing their numbers and replicating, they are however very good at coordinating the healing or regenerative process. In contrast, stem cells that come from bone marrow are very good at replicating and differentiating very rapidly, so they are more action oriented. When you utilize the stem cells from the fat and combine them with the stem cells from the bone marrow, you have a very effective regenerative force, a military like force, where the activating factors act as the orders, fat stem cells act as officers and the bone marrow stem cells act as the cavalry. Victory is in the successful outcome of the patient.